Literature DB >> 15135101

Liquid chromatography-tandem mass spectrometry method for the determination of tranexamic acid in human plasma.

Qi Chang1, Ophelia Q P Yin, Moses S S Chow.   

Abstract

A new method for the determination of tranexamic acid (TA) in human plasma using high performance liquid chromatography with tandem mass spectrometric detection was described. TA and the internal standard, methyldopa, was extracted from a 200 l plasma sample by a one-step deproteination using perchloric acid. Chromatographic separation was performed on an Xtrra MS C18 Column (2.1 mm x 100 mm, 3.5 microm) with the mobile phase consisting of 10% acetonitrile in 2 mM ammonium acetate buffer (pH 3.5) at a flow rate of 0.15 ml/min. The total run time was 5 min for each sample. Detection and quantitation was performed by the mass spectrometer using the multiple reaction monitoring of the precursor-product ion pair m/z 158 --> 95 for TA and m/z 212 --> 166 for methyldopa, respectively. The method was linear over the concentration range of 0.02-10.00 g/ml with lower limit of quantification of 0.02 microg/ml for TA. The intra- and inter-day precision was less than 11% and accuracy ranged -10.88 to 11.35% at the TA concentrations tested. The present method provides a relatively simple and sensitive assay with short turn-around time. The method has been successfully applied to a clinical pharmacokinetic study of TA in 12 healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135101     DOI: 10.1016/j.jchromb.2004.03.013

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Tranexamic acid concentrations associated with human seizures inhibit glycine receptors.

Authors:  Irene Lecker; Dian-Shi Wang; Alexander D Romaschin; Mark Peterson; C David Mazer; Beverley A Orser
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

2.  Current literature in mass spectrometry.

Authors: 
Journal:  J Mass Spectrom       Date:  2004-11       Impact factor: 1.982

3.  Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers.

Authors:  Zoe Kane; Roberto Picetti; Alison Wilby; Joseph F Standing; Stanislas Grassin-Delyle; Ian Roberts; Haleema Shakur-Still
Journal:  Eur J Pharm Sci       Date:  2021-06-01       Impact factor: 4.384

4.  An In Vivo Study of Low-Dose Intra-Articular Tranexamic Acid Application with Prolonged Clamping Drain Method in Total Knee Replacement: Clinical Efficacy and Safety.

Authors:  Paphon Sa-ngasoongsong; Pongsthorn Chanplakorn; Siwadol Wongsak; Krisorn Uthadorn; Tanapong Panpikoon; Paisan Jittorntam; Katcharin Aryurachai; Pantap Angchaisukisiri; Viroj Kawinwonggowit
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

5.  Acetonitrile Adducts of Tranexamic Acid as Sensitive Ions for Quantification at Residue Levels in Human Plasma by UHPLC-MS/MS.

Authors:  Eduarda M P Silva; Luisa Barreiros; Sara R Fernandes; Paula Sá; João P Prates Ramalho; Marcela A Segundo
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.